Diagnostic Considerations

Debilitating medical conditions that have the potential to decrease sexual desire and performance can result in secondary inhibited male orgasm. The most common medical conditions associated with sexual difficulties are diabetes mellitus and hypertension, possibly because of the microvascular and neurovascular changes that are inherent in these conditions.^[3]

Pain syndromes, shortness of breath, angina pectoris, and muscle weakness should be included in the differential diagnosis. Cigarette smoking can cause vascular insufficiency, as well as a decrease in intrapenile nitrous oxide (NO) levels. Excessive consumption of alcohol or the use of other recreational drugs can have a direct inhibitory effect on the genital neurovascular system, an indirect effect via increased prolactin or decreased testosterone production, or both.

The following classes of prescribed medications should be considered in the differential diagnosis^[3]:

Alpha-adrenergic blockers – Prazosin and terazosin (retrograde ejaculation)
Combined alpha- and beta-adrenergic blockers - Labetalol (inhibited ejaculation)
Sympathetic nerve blockers - Guanethidine (erectile dysfunction and retrograde ejaculation)
Antiulcer medications - Cimetidine (decreased libido)
Tricyclic antidepressants (via increased serotonin) - Amitriptyline, desipramine, doxepin, imipramine, maprotiline, nortriptyline, protriptyline (inhibited ejaculation); clomipramine was reported to induce anorgasmia within days of starting treatment, which persisted with minimal tolerance over 5 months of clomipramine therapy^[23])
Monoamine oxidase inhibitors (via increased serotonin) - Isocarboxazid, phenelzine, and tranylcypromine (inhibited ejaculation and decreased libido)
Selective serotonin reuptake inhibitors (via increased serotonin) - Fluoxetine (anorgasmia in 8-30%) and paroxetine (anorgasmia)^[24]
Other antidepressants - Venlafaxine (anorgasmia)^[24]
Neuroleptics (mainly via increased prolactin) – First-generation or typical (haloperidol, thiothixene, perphenazine, and trifluoperazine) and second-generation (risperidone)^[25](inhibited ejaculation, decreased libido)
Mood stabilizers - Topiramate (anorgasmia)^[26]

Workup

Jannini EA, Lenzi A. Ejaculatory disorders: epidemiology and current approaches to definition, classification and subtyping. World J Urol. 2005 Jun. 23(2):68-75. [Medline].
McMahon CG. Management of ejaculatory dysfunction. Intern Med J. 2014 Feb. 44 (2):124-31. [Medline].
Stadler T, Bader M, Uckert S, Staehler M, Becker A, Stief CG. Adverse effects of drug therapies on male and female sexual function. World J Urol. 2006 Dec. 24(6):623-9. [Medline].
Alwaal A, Breyer BN, Lue TF. Normal male sexual function: emphasis on orgasm and ejaculation. Fertil Steril. 2015 Nov. 104 (5):1051-60. [Medline].
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association; 2013:424-6.
Meisel RL, Sachs BD. The physiology of male sexual behavior. In: Knobil E, Neill JD, editors. The Physiology of Reproduction. 3-105. 3rd. New York: Raven Press; 2005.
Hull EM, Du J, Lorrain DS, Matuszewich L. Extracellular dopamine in the medial preoptic area: implications for sexual motivation and hormonal control of copulation. J Neurosci. 1995 Nov. 15(11):7465-71. [Medline].
Bitran D, Hull EM. Pharmacological analysis of male rat sexual behavior. Neurosci Biobehav Rev. 1987 Winter. 11(4):365-89. [Medline].
Giuliano F, Clément P. Serotonin and premature ejaculation: from physiology to patient management. Eur Urol. 2006 Sep. 50(3):454-66. [Medline].
Cantor JM, Binik YM, Pfaus JG. Chronic fluoxetine inhibits sexual behavior in the male rat: reversal with oxytocin. Psychopharmacology (Berl). 1999 Jun. 144(4):355-62. [Medline].
Peeters M, Giuliano F. Central neurophysiology and dopaminergic control of ejaculation. Neurosci Biobehav Rev. 2008. 32 (3):438-53. [Medline].
Wolters JP, Hellstrom WJ. Current concepts in ejaculatory dysfunction. Rev Urol. 2006. 8 Suppl 4:S18-25. [Medline]. [Full Text].
Krüger T, Exton MS, Pawlak C, von zur Mühlen A, Hartmann U, Schedlowski M. Neuroendocrine and cardiovascular response to sexual arousal and orgasm in men. Psychoneuroendocrinology. 1998 May. 23(4):401-11. [Medline].
Krüger TH, Haake P, Chereath D, Knapp W, Janssen OE, Exton MS, et al. Specificity of the neuroendocrine response to orgasm during sexual arousal in men. J Endocrinol. 2003 Apr. 177(1):57-64. [Medline].
Kaplan HS. Post-ejaculatory pain syndrome. J Sex Marital Ther. 1993 Summer. 19(2):91-103. [Medline].
Waldinger MD, Schweitzer DH. Postorgasmic illness syndrome: two cases. J Sex Marital Ther. 2002 May-Jun. 28(3):251-5. [Medline].
Paduch DA, Polzer P, Morgentaler A, Althof S, Donatucci C, Ni X, et al. Clinical and Demographic Correlates of Ejaculatory Dysfunctions Other Than Premature Ejaculation: A Prospective, Observational Study. J Sex Med. 2015 Dec. 12 (12):2276-86. [Medline].
Gingell C, Nicolosi A, Glasser DB, Brock G, Buvat J. Sexual behaviors and functioning in mature men: results of an international survey. 2nd World Congress of Mens Health. 25-27. Vienna; October 2002.
Simons JS, Carey MP. Prevalence of sexual dysfunctions: results from a decade of research. Arch Sex Behav. 2001 Apr. 30(2):177-219. [Medline]. [Full Text].
Dunsmuir WD, Feneley M, Corry DA, Bryan J, Kirby RS. The day-to-day variation (test-retest reliability) of residual urine measurement. Br J Urol. 1996 Feb. 77(2):192-3. [Medline].
Johnson SD, Phelps DL, Cottler LB. The association of sexual dysfunction and substance use among a community epidemiological sample. Arch Sex Behav. 2004 Feb. 33(1):55-63. [Medline].
Komisaruk BR , Beyer-Flores C, Whipple B. Recreational Stimulant Drugs and Orgasm. In: The Science of Orgasm. Johns Hopkins University: 2006:146-148.
Monteiro WO, Noshirvani HF, Marks IM, Lelliott PT. Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial. Br J Psychiatry. 1987 Jul. 151:107-12. [Medline].
Merino MJ, Gonzalez P,Muniz J, Bobes J. Sexual dysfunction in depressed patients undergoing treatment with antidepressants. International Journal of Psychiatry in Clinical Practice. 2000;4:311-317.
Raja M. Risperidone-induced absence of ejaculation. Int Clin Psychopharmacol. 1999 Sep. 14(5):317-9. [Medline].
Sun C, Lay C, Broner S, Silberstein S, Tepper S, Newman L. Reversible anorgasmia with topiramate therapy for headache: a report of 7 patients. Headache. 2006 Oct. 46(9):1450-3. [Medline].
Abdel-Hamid IA, Saleh el-S. Primary lifelong delayed ejaculation: characteristics and response to bupropion. J Sex Med. 2011 Jun. 8(6):1772-9. [Medline].
Salerian AJ, Deibler WE, Vittone BJ, Geyer SP, Drell L, Mirmirani N, et al. Sildenafil for psychotropic-induced sexual dysfunction in 31 women and 61 men. J Sex Marital Ther. 2000 Apr-Jun. 26(2):133-40. [Medline].
Aizenberg D, Shiloh R, Zemishlany Z, Weizman A. Low-dose imipramine for thioridazine-induced male orgasmic disorder. J Sex Marital Ther. 1996 Fall. 22(3):225-9. [Medline].
Althof SE. Psychological interventions for delayed ejaculation/orgasm. Int J Impot Res. 2012 Jul-Aug. 24(4):131-6. [Medline].
Buvat J, Jouannet P, eds. L’ejaculation et ses pertubations. 1984:79-83.
Rowland D, McMahon CG, Abdo C, Chen J, Jannini E, Waldinger MD, et al. Disorders of orgasm and ejaculation in men. J Sex Med. 2010 Apr. 7(4 Pt 2):1668-86. [Medline].
Segraves RT. Considerations for a better definition of male orgasmic disorder in DSM V. J Sex Med. 2010 Feb. 7(2 Pt 1):690-5. [Medline].
Spector IP, Carey MP. Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav. 1990 Aug. 19(4):389-408. [Medline].
Robinson DS, Kajdasz DK, Gallipoli S, Whalen H, Wamil A, Reed CR. A 1-year, open-label study assessing the safety and tolerability of vilazodone in patients with major depressive disorder. J Clin Psychopharmacol. 2011 Oct. 31 (5):643-6. [Medline].

Media Gallery

of 0

Delayed Ejaculation Differential Diagnoses

Diagnostic Considerations

References

Tables

Contributor Information and Disclosures

What would you like to print?